Nick Cheolas Discusses Trump Administration's Antitrust Priorities with S&P Global

Nicholas S. Cheolas, partner in the Litigation Practice, discussed the Trump Administration's willingness to settle health care antitrust matters with S&P Global in the article, "Pharmacy benefit manager suit shows Trump admin's keenness for deals," noting that, "The largest, most significant and obvious change in posture is the willingness to settle. That is very clear. And we have seen many settlements in merger and nonmerger ... matters."